Dexmedetomidine sedation for transesophageal echocardiography during percutaneous atrial septal defect closure in adult

Jae Wook Jung; Gwang Cheol Go; Sang Yoon Jeon; Sira Bang; Ki Hwa Lee; Yong Han Kim; Dong-Kie Kim

doi:10.12669/pjms.296.3616

Authors

Jae Wook Jung Haeundae Paik Hospital, Inje University
Gwang Cheol Go Haeundae Paik Hospital, Inje University
Sang Yoon Jeon Haeundae Paik Hospital, Inje University
Sira Bang Haeundae Paik Hospital, Inje University
Ki Hwa Lee Haeundae Paik Hospital, Inje University
Yong Han Kim Haeundae Paik Hospital, Inje University
Dong-Kie Kim Haeundae Paik Hospital, Inje University

DOI:

https://doi.org/10.12669/pjms.296.3616

Keywords:

Atrial septal defect, Transesophageal echocardiography, Dexmedetomidine sedation.

Abstract

Atrial septal defect (ASD) is second common congenital heart disease that often leads to adult period. Intracardiac or transesophageal echocardiography (TEE) is essential for percutaneous closure of ASD using Amplatzer septal occluder. Dexmedetomidine (DEX), which is a highly selective ?2-agonist, has sedative and analgesic properties without respiratory depression in the clinical dose range. We report percutaneous closure of ASD with TEE under DEX sedation.

doi: http://dx.doi.org/10.12669/pjms.296.3616

How to cite this:Jung JW, Go GC, Jeon SY, Bang S, Lee KH, Kim YH, et al. Dexmedetomidine sedation for transesophageal echocardiography during percutaneous atrial septal defect closure in adult. Pak J Med Sci 2013;29(6):1456-1458.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.